These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4281242)
21. The status of measles after five years of mass vaccination in the USSR. Burgasov PN; Andzaparidze OG; Popov VF Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384 [TBL] [Abstract][Full Text] [Related]
22. Age of measles immunization in tropics. Mirchamsy H; Shafyi A; Mahinpour M; Nazari P Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788 [TBL] [Abstract][Full Text] [Related]
23. [On vaccination against measles with live and attenuated virus (Schwarz strain)]. Monaci V; Imperato C; Battistini A; Nardi G; Grzincich GL; Bellelli E; Mazzeo G Ann Sclavo; 1973; 15(3):134-40. PubMed ID: 4776383 [No Abstract] [Full Text] [Related]
24. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial. Swartz TA; Klingberg W; Klingberg MA Infection; 1974; 2(3):115-7. PubMed ID: 4606362 [No Abstract] [Full Text] [Related]
25. [Humoral immunity indices of measles in reinoculated schoolchildren]. Miroshnikova NK; Smorodinova IP; Smorodintsev AA; Petrova VN Tr Inst Im Pastera; 1983; 61():145-51. PubMed ID: 6235627 [No Abstract] [Full Text] [Related]
26. [Development of measles vaccination in Austria]. Huber EG; Rannon L Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034 [No Abstract] [Full Text] [Related]
27. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235 [TBL] [Abstract][Full Text] [Related]
28. [Unsuitability of children revaccination against measles]. Bolotovskiĭ VM; Titova NS Sov Med; 1981; (9):43-8. PubMed ID: 7313794 [No Abstract] [Full Text] [Related]
29. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells. Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858 [No Abstract] [Full Text] [Related]
30. Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine. Saidi S; Naficy K Am J Dis Child; 1969 Aug; 118(2):209-12. PubMed ID: 5794816 [No Abstract] [Full Text] [Related]
39. [Safety and immunogenicity of measles attenuated live vaccine prepared by master seed lot vaccine of Shanghai-191 strain]. Zhang SJ; Xiao QY; Li FJ Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):423-5. PubMed ID: 20084967 [TBL] [Abstract][Full Text] [Related]
40. Persistence of measles antibody after immunization. Domorázková E; Drevo M J Biol Stand; 1975; 3(2):225-30. PubMed ID: 1126966 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]